Oncolytic adenovirus incorporating TetO sites in the E1A promoter for controlled replication in TetR-expressing mesenchymal stem cells
Mol Ther Oncol. 2026 Jul 10;34(3):201291. doi: 10.1016/j.omton.2026.201291.…
[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial
Lancet. 2026 Aug 6:S0140-6736(26)01092-5. doi: 10.1016/S0140-6736(26)01092-5.…
Editorial: Current insights in melanoma immunology, immune escape and immunotherapy advances
Front Immunol. 2026 May 18;17:1868805. doi: 10.3389/fimmu.2026.1868805.…
Phase I trial of intravenous VCN-01 oncolytic adenovirus and durvalumab in patients with head and neck metastatic squamous cell carcinoma refractory to immunotherapy
Clin Cancer Res. 2026 Jun 8. doi: 10.1158/1078-0432.CCR-26-0601.…
Five-Year Survival with Tebentafusp in Metastatic Uveal Melanoma
Ann Oncol. 2026 May 19:S0923-7534(26)00879-3. doi: 10.1016/j.annonc.2026.05.695.…
Uveal melanoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up
ESMO Open. 2026 Apr;11(4):106888. doi: 10.1016/j.esmoop.2026.106888.…
Recent Advances in Understanding the Biology of Castration-Resistant Prostate Cancer
Urol Clin North Am. 2026 May;53(2):303-315. doi: 10.1016/j.ucl.2026.02.012.…
A rise in double-strand breaks sensitizes tumors to oxidative metabolism inhibitors
Biomed Pharmacother. 2026 Mar 10;197:119184. doi: 10.1016/j.biopha.2026.119184.…
Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trial
ESMO Open. 2025 Dec 2;10(12):105892. doi: 10.1016/j.esmoop.2025.105892.…
Comment on: “Tebentafusp Versus Nivolumab Plus Ipilimumab for Metastatic Uveal Melanoma: An E‑Value Sensitivity Analysis Assessing Effect of Unmeasured Confounders on Observational Associations”
Clin Drug Investig. 2025 Oct 28. doi: 10.1007/s40261-025-01468-1.…
Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 patients
Clin Cancer Res. 2025 Sep 12. doi: 10.1158/1078-0432.CCR-25-1513.…
Toxicity and Biodistribution of the Oncolytic Virus VCN-01 Following Intracranial Injection in Syrian Hamsters
Hum Gene Ther. 2025 Aug 29. doi: 10.1177/10430342251372091. Online…
